Study of Belumosudil Whole Tablets Versus Crushed Tablets in Adults with Chronic Graft Versus Host Disease to Understand Drug Behavior

What this Trial Is About

Researchers are evaluating the pharmacokinetics of belumosudil tabletsboth whole and crushed suspended in waterin adults with chronic graft-versus-host disease cGVHD. The study aims to understand how the drug is processed in the body in these two forms, helping to inform treatment approaches for patients with this condition. This observational research is sponsored by the M.D. Anderson Cancer Center. The study involves monitoring patients who have undergone allogeneic hematopoietic stem cell transplantation HSCT and suffer from cGVHD. Participants will receive belumosudil either as whole tablets or crushed tablets suspended in water. There is no mention of randomization or comparison groups as this is an observational study focusing on drug pharmacokinetics. Participants will be observed throughout the study, which lasts about one year on average. Researchers will assess safety and track any adverse events during this period. The study excludes pregnant women, those on certain medications, and individuals with cognitive impairments. Data collected will help understand how the drug behaves in the body and support future treatment decisions for cGVHD patients.

Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD